Filing Details
- Accession Number:
- 0000914190-10-000677
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-15 16:13:52
- Reporting Period:
- 2010-11-11
- Filing Date:
- 2010-11-15
- Accepted Time:
- 2010-11-15 16:13:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1180145 | Cardiovascular Systems Inc | CSII | Surgical & Medical Instruments & Apparatus (3841) | 411698056 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1370333 | M Edward Brown | 651 Campus Drive St. Paul MN 55112 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-11-11 | 4,000 | $8.74 | 63,068 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2010-11-12 | 3,000 | $8.66 | 66,068 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | $0.00 | 3,977 | 3,977 | Direct | ||
| Common Stock | Restricted Stock Units | $0.00 | 11,628 | 11,628 | Direct | ||
| Common Stock | Restricted Stock Units | $0.00 | 21,739 | 21,739 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 3,977 | 3,977 | Direct | |
| 11,628 | 11,628 | Direct | |
| 21,739 | 21,739 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.7 to $8.79 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Comission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.6 to $8.8 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Comission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment, and shall be payable in shares of the Company's common stock beginning six months following the termination of each director's board membership.
- Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment, and shall be payable in cash or shares of the Company's common stock beginning six months following the termination of each director's board membership; provided, however, that the restricted stock units vest in equal quarterly amounts of 5,435 on each of 9/30/2010, 12/31/2010, and 3/31/2011 and 5,434 on 6/30/2011.
Billionaire Hedge Funds
